ALDX position history
The shares of Aldeyra Therapeutics (ALDX) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 160,800 shares, $1.4M, 0.09% of portfolio
- 2021 Q4: 160,800 shares, $643K, 0.04% of portfolio
- 2022 Q1: 160,800 shares, $715K, 0.06% of portfolio
- 2022 Q2: 160,800 shares, $642K, 0.06% of portfolio
- 2022 Q3: 160,800 shares, $859K, 0.07% of portfolio
- 2022 Q4: 160,800 shares, $1.1M, 0.10% of portfolio
- 2023 Q1: 160,800 shares, $1.6M, 0.13% of portfolio
- 2023 Q2: 160,800 shares, $1.3M, 0.11% of portfolio
- 2023 Q3: 160,800 shares, $1.1M, 0.10% of portfolio
- 2023 Q4: 450,930 shares, $1.6M, 0.14% of portfolio, Add +180.4%
- 2024 Q1: 225,465 shares, $737K, 0.08% of portfolio, Reduce −50.0%
- 2024 Q2: 225,465 shares, $746K, 0.09% of portfolio
- 2024 Q3: 225,465 shares, $1.2M, 0.16% of portfolio
- 2024 Q4: 225,465 shares, $1.1M, 0.17% of portfolio
- 2025 Q1: 225,465 shares, $1.3M, 0.25% of portfolio
- 2025 Q2: 225,465 shares, $864K, 0.18% of portfolio
- 2025 Q3: 225,465 shares, $1.2M, 0.22% of portfolio
- 2025 Q4: 225,465 shares, $1.2M, 0.16% of portfolio
- 2026 Q1: 155,709 shares, $263K, 0.04% of portfolio, Reduce −30.9%
- 2026 Q2: 155,709 shares, $332K, 0.05% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|